These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33497125)

  • 1. New Drugs for Rare Disorders.
    Aschenbrenner DS
    Am J Nurs; 2021 Feb; 121(2):27. PubMed ID: 33497125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Shappell H; Massaro J; D'Agostino RB; Brazier J; Campbell SE; Kleinman ME; Kieran MW
    JAMA; 2018 Apr; 319(16):1687-1695. PubMed ID: 29710166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Kleinman ME; Massaro J; D'Agostino RB; Shappell H; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland RH; Nazarian A; Snyder BD; Ullrich NJ; Silvera VM; Liang MG; Quinn N; Miller DT; Huh SY; Dowton AA; Littlefield K; Greer MM; Kieran MW
    Circulation; 2016 Jul; 134(2):114-25. PubMed ID: 27400896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment.
    Ullrich NJ; Kieran MW; Miller DT; Gordon LB; Cho YJ; Silvera VM; Giobbie-Hurder A; Neuberg D; Kleinman ME
    Neurology; 2013 Jul; 81(5):427-30. PubMed ID: 23897869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonafarnib for cancer and progeria.
    Wong NS; Morse MA
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1043-55. PubMed ID: 22620979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib.
    Gordon LB; Campbell SE; Massaro JM; D'Agostino RB; Kleinman ME; Kieran MW; Moses MA
    Pediatr Res; 2018 May; 83(5):982-992. PubMed ID: 29342131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hutchinson-Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential Therapies.
    Xu S; Jin ZG
    Trends Biochem Sci; 2019 Jul; 44(7):561-564. PubMed ID: 31036409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progeria: a rare genetic premature ageing disorder.
    Sinha JK; Ghosh S; Raghunath M
    Indian J Med Res; 2014 May; 139(5):667-74. PubMed ID: 25027075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving from gene discovery to clinical trials in Hutchinson-Gilford progeria syndrome.
    King AA; Heyer GL
    Neurology; 2013 Jul; 81(5):408-9. PubMed ID: 23897868
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies.
    Suzuki M; Jeng LJB; Chefo S; Wang Y; Price D; Li X; Wang J; Li RJ; Ma L; Yang Y; Zhang X; Zheng N; Zhang K; Joseph DB; Shroff H; Doan J; Pacanowski M; Smpokou P; Donohue K; Joffe HV
    Genet Med; 2023 Feb; 25(2):100335. PubMed ID: 36507973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria.
    Rampogu S; Baek A; Son M; Zeb A; Park C; Kumar R; Lee G; Kim D; Choi Y; Cho Y; Park Y; Park SJ; Lee KW
    Biomed Res Int; 2017; 2017():5270940. PubMed ID: 29226142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.
    Gordon LB; Kleinman ME; Miller DT; Neuberg DS; Giobbie-Hurder A; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland R; Snyder BD; Fligor B; Bishop WR; Statkevich P; Regen A; Sonis A; Riley S; Ploski C; Correia A; Quinn N; Ullrich NJ; Nazarian A; Liang MG; Huh SY; Schwartzman A; Kieran MW
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16666-71. PubMed ID: 23012407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome.
    Gordon CM; Cleveland RH; Baltrusaitis K; Massaro J; D'Agostino RB; Liang MG; Snyder B; Walters M; Li X; Braddock DT; Kleinman ME; Kieran MW; Gordon LB
    Bone; 2019 Aug; 125():103-111. PubMed ID: 31077852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progeria: case report and new drugs perspectives.
    Grana AG; Silva AA; Moura Filho FR; Rodrigues Ferreira Rocha de Alencar R; Chicre Bandeira de Melo P
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e293-e294. PubMed ID: 29377371
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
    Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
    Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An encouraging progress report on the treatment of progeria and its implications for atherogenesis.
    Oshima J; Hisama FM; Martin GM
    Circulation; 2014 Jul; 130(1):4-6. PubMed ID: 24795391
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug development for progeria yields insights into normal aging.
    Jiang K
    Nat Med; 2013 May; 19(5):515. PubMed ID: 23652088
    [No Abstract]   [Full Text] [Related]  

  • 18. Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.
    Arnold R; Vehns E; Randl H; Djabali K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
    Falls BA; Zhang Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progeria and the early aging in children: a case report.
    Carvalho VO; Celli A; Bancke Laverde BL; Cunico C; Santos Piedade G; Lucas de Mello M; Beirao Junior PS
    Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.